Dual antiplatelet therapy (DAPT), the combination of aspirin (ASA), and a P2Y12 inhibitor, protects against stent thrombosis new atherothrombotic events after implantation or an acute coronary syndrome, but exposes patients to increased risk bleeding. In most current practices, inhibitor is stopped at 6 12 months ASA continued indefinitely. The advent safer stents, with less thrombosis, has cha...

There has been much consideration of the drive for organisations to create value for shareholders, and much argument that the creation of value for shareholders is derived from the reduction of operational costs. The proponents of the techniques of shareholder value would deny this and argue that the creation of value for shareholders derives from improved decision making. Thus the discourse of...